Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
Status:
Recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of CYP2C19 and ABCB1 genes on pharmacokinetics of
lansoprazole in children with mild gastroesophageal reflux (GER) and uncontrolled asthma. It
will determine if genotype-guided lansoprazole dosing of lansoprazole improves GER and asthma
control.